Nano-engineered mesenchymal stem cells as targeted therapeutic carriers

Journal of Controlled Release

Volumn 196, Issue , 2014, Pages 243-251

  Sadhukha, Tanmoy ^a   O'Brien, Timothy D ^b   Prabha, Swayam ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Nanoparticles Mesenchymal stem cells Chemotherapy Targeted drug delivery Drug efflux

Indexed keywords

MESENCHYMAL STEM CELL;

DRUG CARRIER; MULTIDRUG RESISTANCE PROTEIN; NANOPARTICLE; PACLITAXEL; ANTINEOPLASTIC AGENT; LACTIC ACID; NANOMATERIAL; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

A549 CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER; MESENCHYMAL STEM CELL; MOUSE; NANOENGINEERING; NONHUMAN; PROTEIN EXPRESSION; SPLEEN; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; MESENCHYMAL STROMA CELL; NEOPLASMS; SCID MOUSE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; NANOSTRUCTURES; NEOPLASMS; P-GLYCOPROTEIN; POLYGLYCOLIC ACID; TISSUE DISTRIBUTION;

EID: 84908456142     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.10.015     Document Type: Article

References (39)

1. M.E. Davis, Z.G. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
2. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
3. V.P. Chauhan, T. Stylianopoulos, J.D. Martin, Z. Popovic, O. Chen, W.S. Kamoun, M.G. Bawendi, D. Fukumura, and R.K. Jain Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner Nat. Nanotechnol. 7 2012 383 388
4. D. Groshar, A.J. McEwan, M.B. Parliament, R.C. Urtasun, L.E. Golberg, M. Hoskinson, J.R. Mercer, R.H. Mannan, L.I. Wiebe, and J.D. Chapman Imaging tumor hypoxia and tumor perfusion J. Nucl. Med. 34 1993 885 888
5. V.P. Torchilin Passive and active drug targeting: drug delivery to tumors as an example Handb. Exp. Pharmacol. 2010 3 53
6. C. Chen Weihsu, X. Zhang Andrew, and S.-D. Li Limitations and niches of the active targeting approach for nanoparticle drug delivery Eur. J. Nanomed. 2012 89
7. Z. Sun, S. Wang, and R.C. Zhao The roles of mesenchymal stem cells in tumor inflammatory microenvironment J. Hematol. Oncol. 7 2014 14
8. K. Shah Mesenchymal stem cells engineered for cancer therapy Adv. Drug Deliv. Rev. 64 2012 739 748
9. X. Chen, X. Lin, J. Zhao, W. Shi, H. Zhang, Y. Wang, B. Kan, L. Du, B. Wang, Y. Wei, Y. Liu, and X. Zhao A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs Mol. Ther. 16 2008 749 756
10. Z. Gao, L. Zhang, J. Hu, and Y. Sun Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles Nanomed. Nanotechnol. Biol. Med. 9 2013 174 184
11. S. Prabha, B. Sharma, and V. Labhasetwar Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice Cancer Gene Ther. 19 2012 530 537
12. J.K. Vasir, and V. Labhasetwar Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv. Drug Deliv. Rev. 59 2007 718 728
13. Y.B. Patil, S.K. Swaminathan, T. Sadhukha, L. Ma, and J. Panyam The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance Biomaterials 31 2010 358 365
14. Y. Patil, T. Sadhukha, L. Ma, and J. Panyam Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance J. Control. Release 136 2009 21 29
15. M. Roger, A. Clavreul, M.C. Venier-Julienne, C. Passirani, L. Sindji, P. Schiller, C. Montero-Menei, and P. Menei Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors Biomaterials 31 2010 8393 8401
16. T. Sadhukha, T.S. Wiedmann, and J. Panyam Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy Biomaterials 34 2013 5163 5171
17. E. Mariani, and A. Facchini Clinical applications and biosafety of human adult mesenchymal stem cells Curr. Pharm. Des. 18 2012 1821 1845
18. S. Wang, X. Qu, and R.C. Zhao Clinical applications of mesenchymal stem cells J. Hematol. Oncol. 5 2012 19
19. A. Trounson, R.G. Thakar, G. Lomax, and D. Gibbons Clinical trials for stem cell therapies BMC Med. 9 2011 52
20. W. Zhao, D.G. Phinney, D. Bonnet, M. Dominici, and M. Krampera Mesenchymal stem cell biodistribution, migration, and homing in vivo Stem Cells Int. 2014 2014 292109
21. A. Sohni, and C.M. Verfaillie Mesenchymal stem cells migration homing and tracking Stem Cells Int. 2013 2013 130763
22. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Preat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2012 505 522
23. J. Panyam, W.Z. Zhou, S. Prabha, S.K. Sahoo, and V. Labhasetwar Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery FASEB J. 16 2002 1217 1226
24. M.D. Chavanpatil, Y. Patil, and J. Panyam Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux Int. J. Pharm. 320 2006 150 156
25. M. Gnecchi, and L.G. Melo Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium Methods Mol. biol. 482 2009 281 294
26. B. Semete, L. Booysen, Y. Lemmer, L. Kalombo, L. Katata, J. Verschoor, and H.S. Swai In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems Nanomed. Nanotechnol. Biol. Med. 6 2010 662 671
27. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347
28. M.S. Amini-Fazl, H. Mobedi, and J. Barzin Investigation of aqueous stability of taxol in different release media Drug Dev. Ind. Pharm. 40 2014 519 526
29. J. Tian, and V.J. Stella Degradation of paclitaxel and related compounds in aqueous solutions II: nonepimerization degradation under neutral to basic pH conditions J. Pharm. Sci. 97 2008 3100 3108
30. L. Mu, and S.S. Feng A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS J. Control. Release 86 2003 33 48
31. J. Panyam, and V. Labhasetwar Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells Pharm. Res. 20 2003 212 220
32. T. Sadhukha, and S. Prabha Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin AAPS PharmSciTech 15 2014 1029 1038
33. J. Oswald, S. Boxberger, B. Jorgensen, S. Feldmann, G. Ehninger, M. Bornhauser, and C. Werner Mesenchymal stem cells can be differentiated into endothelial cells in vitro Stem Cells 22 2004 377 384
34. S.J. Baek, S.K. Kang, and J.C. Ra In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors Exp. Med. Biol. 43 2011 596 603
35. L. Pascucci, V. Cocce, A. Bonomi, D. Ami, P. Ceccarelli, E. Ciusani, L. Vigano, A. Locatelli, F. Sisto, S.M. Doglia, E. Parati, M.E. Bernardo, M. Muraca, G. Alessandri, G. Bondiolotti, and A. Pessina Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery J. Control. Release 192 2014 262 270
36. S. Kidd, E. Spaeth, J.L. Dembinski, M. Dietrich, K. Watson, A. Klopp, V.L. Battula, M. Weil, M. Andreeff, and F.C. Marini Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging Stem Cells 27 2009 2614 2623
37. J.L. Eiseman, N.D. Eddington, J. Leslie, C. MacAuley, D.L. Sentz, M. Zuhowski, J.M. Kujawa, D. Young, and M.J. Egorin Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice Cancer Chemother. Pharmacol. 34 1994 465 471
38. H. Yagi, and Y. Kitagawa The role of mesenchymal stem cells in cancer development Front. Genet. 4 2013 261
39. B. Sharma, W. Ma, I.M. Adjei, J. Panyam, S. Dimitrijevic, and V. Labhasetwar Nanoparticle-mediated p53 gene therapy for tumor inhibition Drug Deliv. Transl. Res. 1 2011 43 52